Oriented by user needs, and based on product quality wholeheartedly provide users with quality Tetracaine hydrochloride powder, N N N Trimethylethylenediamine, 3 methyl 4 piperidone products! We have extensive goods supply and the price is our advantage. Rapid response to the market requires strong product R & D capacity and efficient and high-quality manufacturing capacity as the cornerstone. We will adhere to the concept of scientific development, safety and efficiency, harmony and win-win, and are willing to cooperate sincerely with friends from all walks of life and work together for a win-win situation.
Tetracaine Hcl is a compound. If you want to detect its content, you must use neutralization titration. After this method, some chemical information can be obtained as follows, refractive index 1.5200 ( estimate ), Storage conditions 2-8 ° C, solubility alcohol : solublesoluble 40 parts of solvent, shape neat, Acidity coefficient ( pKa ) 8.39 ( at 25 °C ), Soluble in water at 50mg / ml. it also known as Tetracaine hydrochloridehcl, is a local anesthetic. Its molecular formula is C15H25ClN2O2, with a molecular weight of 300.8. It is a white crystalline powder. It is easy to dissolve in water, with a solubility of 1 gram/milliliter (25 ℃). It is also easily soluble in ethanol, chloroform, and benzene, but its solubility is lower in petroleum ether and ethyl acetate.

|
|
|

Tetracaine Hcl is mainly characterized by its easy penetration into the mucosa, so it is often used for mucosal surface anesthesia, intraspinal block and nerve block. The common method of tetracaine hydrochloride is surface local anesthesia.
Hydrolysis reaction:
Tetracaine hydrochloride is prone to hydrolysis in acidic or alkaline environments, which may affect its biological activity. For example, in acidic environments (such as gastric acid), the ester bonds in its molecules can be hydrolyzed to produce substances such as p-aminobenzoic acid and 2-dimethylamine ether.
Hydrolysis is a type of chemical reaction that decomposes a single substance into two or more substances in the presence of water. When Tetracaine Hydrochloride is present in water, it undergoes a hydrolysis reaction. Usually, hydrolysis is caused by hydroxyl ions (OH ^ -) in water attacking the carbonyl group (C=O) of Tetracaine Hydrochloride.
The carbonyl group in the Tetracaine Hydrochloride molecule is C (=O) N (R1) C2=C (CN (C) C) C=C (NC) C2=NC1=C (N) C=CC=C1, where R1 represents the larger alkyl group. When Tetracaine Hydrochloride is dissolved in water, water molecules will combine with carbonyl oxygen atoms to form a stable hydrogen bond. This will cause the Tetracaine Hydrochloride molecule to remain open and susceptible to attack by hydroxide ions in the water.
The hydrolysis of Tetracaine Hydrochloride may lead to the following reactions:
The molecules of Tetracaine Hydrochloride contain a larger acetyl group. When water molecules attack carbonyl groups, they can remove acetyl groups from Tetracaine Hydrochloride molecules, producing a corresponding carboxylic acid. The chemical formula of this reaction is C20H28ClN3O2·HCl + H2O → C19H25ClN2O3 + CH3COOH + HCl
Among them, CH3COOH is the carboxylic acid produced, and HCl is the hydrochloric acid ion.
Tetracaine Hydrochloride molecules also contain an amine group that can be used to form bonds, thereby binding drug molecules to corresponding receptors. When water molecules attack Tetracaine Hydrochloride molecules, the amine group may remove an acetyl group from the molecule, forming the corresponding amine. The chemical formula of this reaction is
C20H28ClN3O2·HCl + H2O → C20H27ClN2O + C2H5OH + HCl
Among them, C2H5OH is the ethanol produced and can be evaporated from the reaction mixture
Water molecules can also bind to the C-N bond in Tetracaine Hydrochloride molecules, forming two molecules. This reaction is very unfavorable and can lead to the deactivation of drug molecules. The chemical formula of this reaction is
C20H28ClN3O2·HCl + H2O → C10H13ClN2O + C10H15ClN2O + HCl
Among them, C10H13ClN2O and C10H15ClN2O are hydrolysis products.


The main market of tetracaine hydrochloride is concentrated in the medical field, especially in the fields of surgery, anesthesia, and pain relief, which have extensive applications. With the rapid development of the global medical industry, the demand for local anesthetics and analgesics continues to grow, driving the expansion of the tetracaine hydrochloride market.
Specifically, the United States and Europe are major producers and consumers, occupying a dominant position in the global market. Among them, the United States has the largest market share, with the majority of brand research and development, production, and market sales concentrated in the United States. The European market is mainly produced by Germany and the United Kingdom.
In recent years, with the rapid development of China's medical industry and the acceleration of domestic population aging, the domestic market has gradually emerged and is expected to maintain a high growth rate in the coming years.

Tetracaine HCl, also known as tetracaine hydrochloride, is a calcium channel conformational inhibitor and a highly effective local anesthetic mainly used for mucosal anesthesia. It can be clinically used for infiltration anesthesia, nerve block anesthesia, and epidural anesthesia. The development prospects of lidocaine hydrochloride can be analyzed from the following aspects:
1.Market demand
This substance, as a local anesthetic, has a wide range of applications in the medical field. With the continuous advancement of medical technology and the increasing demand for medical services, the market demand for lidocaine hydrochloride is expected to continue to grow. In addition to the medical field, it may also find new applications in other industries such as cosmetics and feed, further expanding its market space.
2.Technological development
- With the continuous advancement of science and technology, its production process and quality control technology will continue to improve, thereby increasing its output and quality, reducing production costs, and enhancing its market competitiveness. The development of new drug formulations may also bring new development opportunities for the substance, such as developing more user-friendly and safer formulations to meet the needs of different patients.
3.Policy support
- The government's continuous increase in investment and support for the healthcare industry has provided a favorable policy environment for the research and production of drugs such as lidocaine hydrochloride.
- In addition, with the increasingly improved regulatory policies in the pharmaceutical industry, the safety and efficacy of these drugs will be better guaranteed, which will contribute to the healthy development of their market.
4.Competitive landscape
- At present, there are multiple manufacturers of this substance in the market, and the competition is quite fierce. However, with the continuous growth of market demand and technological advancements, some companies with technological and market advantages are expected to stand out in the competition and become industry leaders.
- At the same time, cooperation and mergers and acquisitions between enterprises may also become important driving forces for market development, achieving win-win development through resource integration and complementary advantages.
5.Environmental requirements
- With the continuous improvement of environmental awareness, countries' environmental requirements for chemicals are also gradually increasing. The production and use of this substance require compliance with relevant environmental standards and regulations to ensure that it does not cause pollution to the environment.
- Therefore, enterprises need to strengthen their environmental awareness and technological investment, adopt green production processes and environmentally friendly materials, and reduce environmental pollution and energy consumption during the production process.
Tetracaine hydrochloride powder can be made into injections, sprays and gels through different processes
1. Preparation of injection solution
Prescription:
Tetracaine hydrochloride: appropriate amount (according to the required concentration to determine)
Sodium chloride: appropriate amount (for regulating osmotic pressure)
Water for injection: add to the required volume
Preparation:
Take it and sodium chloride, add appropriate amount of water for injection and stir to dissolve.
Adjust the pH of the solution to 4.0~4.5 to ensure the stability and effectiveness of the drug.
Continue to add water for injection to make the solution volume reach the required amount and stir well.
Take a sample to determine the content, qualified and filtered until the solution is clear.
Fill and seal in a sterile container, with 100 ℃ circulating steam sterilization for 30 minutes, that is, the bupivacaine hydrochloride injection.
2. the preparation of spray
Prescription:
Tetracaine hydrochloride: 30g
Epinephrine hydrochloride: 10mg (can enhance the effect of local anesthesia, reduce surgical bleeding)
PVA-124 (polyvinyl alcohol): appropriate amount (as a film-forming material)
Ethanol (60%): 650ml (as a solvent, acts as an antiseptic)
Propylene glycol: 100ml (moisturizing and transdermal promotion)
Distilled water: appropriate amount
Method of Preparation:
Take PVA-124, add distilled water to fully dissolve and then heat it to dissolve into a gel.
Take another 60% ethanol and add propylene glycol and stir well, then add Tetracaine hydrochloride and epinephrine hydrochloride and stir until completely dissolved.
Add the above solution into the PVA-124 gum liquid, stir well while adding, that is to say, the bupivacaine hydrochloride spray.
Parameters such as pH and viscosity can be further adjusted as required.
3. Precautions
During the preparation process, the quality and proportion of raw materials should be strictly controlled to ensure the stability and effectiveness of the product.
The preparation environment should be kept clean to avoid contamination.
After preparation, strict quality control and testing should be carried out to ensure that the product complies with relevant standards and regulations.
In the process of use, it should follow the guidance and advice of doctors to ensure the safety and effectiveness of the medication.
The above information is for reference only. Specific preparation methods and processes may vary depending on the actual situation. In actual production, it should be adjusted and optimized according to specific needs and conditions.
The enterprise has reformulated a sound and rigorous management mechanism, and we have excellent development and testing equipment, equipped with a professional network information platform, which has gathered many high-end talents in the Tetracaine HCl CAS 136-47-0 Tetracaine Powder, Benzocaine, Lidocaine HCl, Procaine HCl, Tetracaine Hydrochloride Safe Delivery to Ca USA UK industry, and cultivated a professional team with excellent technology and quick response. The company will provide customers with high-quality services in a sincere, convenient and efficient manner with a pioneering and innovative business philosophy, dynamic management mechanism, perfect service, and customer first, mutual benefit and win-win results. Our company's operation is expanding to a comprehensive modern enterprise operation including mergers and acquisitions and capital operation.



